A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
JAMA Psychiatry March 1, 2017 Gerard Sanacora, Mark A Frye, William M. Mcdonald et al. 577 citations
IMPORTANCE: Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. Despite the relatively small sample sizes, lack of longer-term data on efficacy, and limited data on safety provided by these studies, they have led to increased use of...